Table 3.
Follow-up periods | P value | |||||
---|---|---|---|---|---|---|
Baseline | 2 weeks | 4 weeks | P1 | P2 | P3 | |
Treatment group (N = 25) | 6.84 ± 1.03 | 6.92 ± 0.91 | 7.04 ± 1.49 | 0.99 | 0.98 | 0.98 |
Placebo group (N = 25) | 6.56 ± 1.16 | 6.64 ± 1.08 | 6.91 ± 1.29 | 0.99 | 0.84 | 0.99 |
P value | 0.50 | 0.42 | 0.87 |
P1 baseline versus 2 weeks; P2 baseline versus4 weeks; and P3 2 weeks versus 4 weeks.